Narrow Results

Innovation in Academic Medicine.

Merck Serono awards Grant for Growth Innovation (GGI) for the first time.

National Cancer Institute awards KIYATEC nearly $2M to fund 3D breast cancer, 3D brain cancer micro-tumor development.

Frost & Sullivan honors 2014 Growth, Innovation & Leadership Award winners.

Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia's Children's Cancer Institute.

Daiichi Sankyo further expands TaNeDS collaborative drug discovery program in Europe.

Veolia Water Technologies South-East Asia to provide advanced water solutions for Tun Razak Exchange Project in Malaysia.

Biocept and Rosetta Genomics collaborate to evaluate microRNAs from circulating tumor cells.

Biocept expands collaboration with MD Anderson Cancer Center.

NUS Researchers Create Palm-Size Device for Quick, Effective Treatment of Common Hearing Disorder.

World Asthma Day: Managing and Living with Asthma.

DARZALEX^® (daratumumab) Available in Singapore, Following Accelerated Approval by the Health Sciences Authority.

Managing Liver Cancer as a Global Health Problem.

Bayer and NUS Enterprise Announce Winners of Grants4Apps^® Singapore Open Innovation Challenge.

Exclusive Interviews with the Grants4Apps^® winners: I. EyeDEA, Singapore, II. GlycoLeap by Holmusk, Singapore and III. PillPocket, Thailand.